EXIQON SEEK FIND VERIFY
Live / Registered — Cancelled — Section 71 (as of 26 Feb 2021)
What this means for you
Registered since 29 Jun 2010. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79062177
- Registration number
- 3810965
- Mark type
- Slogan / phrase
- Filed
- 28 Oct 2008
- Published for opposition
- 13 Apr 2010
- Registered
- 29 Jun 2010
- Attorney of record
- LEIGH ANN LINDQUIST
Goods and services
- Class 001 — Chemicals: Chemical products for diagnostic, industrial and scientific purposes, namely, industrial chemicals, catalysts for chemical and biochemical processes and chemicals used in the manufacture of pharmaceuticals and drug candidates, all of the aforementioned being for use in life science research, for use in the manufacture of anti-cancer drugs and drug candidates, and for use in in vitro diagnostics and in molecular and cancer diagnostics not for medical or veterinary purposes; Biochemical products for analyses of nucleic acids, nucleotides, oligonucleotides, DNA and RNA, namely, biochemical catalyst, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays not for medical or veterinary purposes, and molecular and cell-based oncology assays not for medical and veterinary purposes; Chemical reagents not for medical or veterinary purposes; Biochemical kits, consisting of biochemical preparations in the nature of biochemical catalysts, biochemical reagents commonly known as probes, and enzymes, for analysis of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA not for medical or veterinary purposes; Biochemical reagents, commonly known as probes for analyses of DNA, RNA, nucleotides, oligonucleotides, nucleic acids and for detecting RNA and microRNA not for medical or veterinary purposes
- Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical, medical and veterinary use, namely, clinical medical reagents, diagnostic reagents, and assays for medical use; Chemico-pharmaceutical preparations, namely, biomedical preparations and assays for use in the detection of cancer in humans and animals and for use in oncology and pharmaceutical preparations for use in the prevention, treatment and cure of cancer; Chemical reagents for medical and veterinary purposes; Chemical preparations for medical therapeutic purposes, namely, preparations for the detection of cancer in humans and animals, for the treatment, prevention and cure of cancer, and for use in oncology; Diagnostic preparations for medical and veterinary purposes
- Class 042 — Scientific and technological services: Scientific research, development and consultancy relating thereto in the fields of chemical analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA; Biotechnological consultancy relating to DNA peptide and nucleotide syntheses
- Class 045 — Legal and security services: [ Licensing of intellectual property rights, including patent utilisation concerning chemical analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA; Consultancy services concerning the issuing of intellectual property rights licenses, and of licenses relating to the use of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA ]
Owner
- QIAGEN GmbH, DE
- Exiqon A/S, DK-2950 Vedbæk, DK
- Exiqon A/S, DK-2950 Vedbæk, DK
- Exiqon A/S, DK-2950 Vedbæk, DK
Prior registrations
Prosecution history
- 14 Jan 2022 — TOTAL INVALIDATION PROCESSED BY THE IB
- 16 Dec 2021 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 16 Dec 2021 — INVALIDATION PROCESSED
- 26 Oct 2021 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 02 Apr 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 26 Feb 2021 — CANCELLED SECTION 71
- 06 Jan 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Jan 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Jun 2019 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 19 Apr 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 15 Mar 2019 — CHANGE OF OWNER RECEIVED FROM IB
- 12 Apr 2018 — INTERNATIONAL REGISTRATION RENEWED
- 30 Jun 2017 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Jun 2017 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 02 Mar 2017 — GENERIC MADRID TRANSACTION SENT TO IB